The global wound care biologics market was valued at USD 1,648.7 million in 2018, which will grow at a CAGR of 6.7% during the forecast period.
Industry Insights by Product (Growth Factors (PDGF, EGF, IGF, TGF-β, FGF, Others), Skin Substitutes (Acellular Animal-Derived, Human Tissue-Derived, Biosynthetic), Cell-Based (Viable, Non-Viable), Collagen-Based, Enzyme-Based, Others), by Durability (Permanent, Temporary), by Application (Chronic, Acute), by End-User (Hospital and Specialty Wound Care Clinic, Home Healthcare, Others), by Geography (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Japan, China, India, Australia, South Korea, Brazil, U.A.E, Saudi Arabia, South Africa, South Africa)
Globally, wound care biologics industry is driven by the factors such as the mounting occurrence of the surgical wound and wound ulcer, rising healthcare expenditure, need for evidence-based treatment for chronic wounds, awareness programs for advanced wound care treatment and management, and technological advancements.
Get a free copy of sample report: https://www.vynzresearch.com/healthcare/wound-care-biologics-market/request-sample
The market for wound care biologics is witnessing growth due to the increasing occurrence of the surgical wound and wound ulcers. With the expanding geriatric population, and mounting occurrence of lifestyle-associated diseases such as diabetes has resulted in the demand of wound care biologics for the management and treatment of wounds, which further decreases the length of stay in the hospital and reduces the cost involved. This offers market players immense opportunities for wound care biologics products, which will drive their revenue growth.
Skin substitutes to hold the largest share in the wound care biologics market, globally
On the basis of product, the global wound care biologics market is categorized into growth factors, skin substitutes, cell-based, collagen-based, enzyme-based, and others. Of all, skin substitutes account for the largest share in the market. The global skin substitutes market is also anticipated to witness significant growth during the forecast period. Growth factors are further categorized into platelet-derived growth factors (PDGF), epidermal growth factors (EGF), insulin-like growth factors (IGF), transforming growth factor-beta (TGF-β), fibroblast growth factors (FGF), and others; whereas skin substitutes are further segmented into acellular animal-derived, human tissue-derived, and biosynthetic. Another category of cell-based products includes viable and non-viable segments.
Based on durability, the wound care biologics market is segmented into permanent and temporary biologics. The demand for temporary biologics has witnessed considerable growth over the last few years due to the increasing burn incidences and their lower cost compared to permanent biologics.
Based on application, the wound care biologics market is segmented into chronic and acute. Among the two categories, chronic would care biologics hold the larger market share due to the growing geriatric population and increasing incidence of pressure ulcers, diabetic foot ulcer and other ulcers.
Based on end-user, the wound care biologics market is segmented into hospitals and specialty wound care clinics, home healthcare and other end users. The hospital and specialty wound clinics are estimated to account the largest share in the wound care market due to increasing in hospitals and clinics, due to improving healthcare infrastructure in developing countries, increasing number of chronic wound cases and increasing incidence of diabetes.
Explore key industry insights in 97 tables and 55 figures from the 135 pages of report, “Global Wound Care Biologics Market – Analysis and Forecast (2019-2024) Industry Insights by Product (Growth Factors (PDGF, EGF, IGF, TGF-β, FGF, Others), Skin Substitutes (Acellular Animal-Derived, Human Tissue-Derived, Biosynthetic), Cell-Based (Viable, Non-Viable), Collagen-Based, Enzyme-Based, Others), by Durability (Permanent, Temporary), by Application (Chronic, Acute), by End-User (Hospital and Specialty Wound Care Clinic, Home Healthcare, Others), by Geography (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Japan, China, India, Australia, South Korea, Brazil, U.A.E, Saudi Arabia, South Africa, South Africa)”
Geography Insight
Geographically, North America is the largest wound care biologics market as the region is home to a large number of industry players. Some of the other factors leading to the growth of the North American market are growing research activities, the highest healthcare expenditure globally, and increasing prevalence of diabetes. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2015 approximately 23.1 million people in the U.S. had diabetes. The increasing cases of burn cases and increasing investment for research and development are also supporting the growth of the North American market.
Asia-Pacific is observed to witness the fastest growth in the market as the region comprises of largest population and the awareness for wound management is increasing rapidly among them. In addition, government support for wound management is also creating a positive impact on the wound care biologics market growth in the region.
Competitive Insight
Some of the key players operating in the global wound care biologics market are Integra LifeSciences Corporation, MiMedx Group Inc., Wright Medical Group N.V., Osiris Therapeutics Inc., Vericel Corporation, Kerecis Limited, Anika Therapeutics Inc., Acell Inc., Skye Biologics Inc., Solsys Medical, Marine Polymer Technologies Inc., Kerecis Limited, Smith & Nephew plc, and Mölnlycke Health Care AB.
Do you have any specific research requirement? Ask for customization: https://www.vynzresearch.com/healthcare/wound-care-biologics-market/customize-report
Primary Research
In the primary data collection process, there are several sources interviewed in order to obtain precise quantitative and qualitative information for this study. The primary sources those are included for the data collection of this study comprises of manufacturers, commercial growers, industry consultants and others key industry experts. There are several others sources that helped in gaining insightful information about this market are CEOs, marketing and sales directors, vice presidents, and key opinion leaders from various key companies operating in the global wound care biologicals market. Primary research in this report has been conducted for estimating market size, market dynamics, and strategies adopted by the key players in this market.
Secondary Research
Secondary sources referred for this research report includes association for wound care biologicals, business filings such as financial statements, annual reports, investor presentations and trade associations. The secondary data has been used for estimating overall market size and growth of the wound care biologicals market that has been authenticated with the supporting facts gathered through primary data collection.
The Report Offers:
Benefits of Report Purchase from VynZ:
Detailed Research
We provide accurate data and in-depth analysis with all-inclusive coverage.
Robust Research Methodology
Robust research methodology and data triangulation to ensure high-quality report.
Analyst Support
24*7 analyst support – Pre and post purchase of the report as well as during the project tenure.
Sales Support
24*7 sales support – Hassle free delivery of the report and quick response and support by sales team.
Free Customization
20% post purchase free customization to meet your requirements.
Customer Satisfaction
We claim full customer satisfaction as our core values lie in building long term relationship.
Security
High level of data security and confidentiality of your information.
Global Wound Care Biologics Market Coverage
Product Insight and Forecast 2014-2024
Durability Insight and Forecast 2014-2024
Application Insight and Forecast 2014-2024
End User Insight and Forecast 2014-2024
Geographical Segmentation
Wound Care Biologics Market by Region
North America
Europe
Asia-Pacific (APAC)
Rest of the World (RoW)
More from VynZ Research
Global Wound Dressing Market Analysis and Forecast to 2024
The global wound dressing market is predicted to grow at 5.7% CAGR during the forecast period with the market size reaching USD 14.3 billion by 2024. Chronic wound imposes a burden on an individual and the healthcare system. Wound healing is a complex process which requires a suitable environment to promote the healing process. Wound dressing helps to heal the wound and prevent issues such as complications or infection.
Explore more at https://www.vynzresearch.com/healthcare/wound-dressing-market
Global Scar Treatment Market Analysis and Forecast to 2024
The global scar treatment market is predicted to grow at 11.9% CAGR during the forecast period with the market size reaching USD 37.6 billion by 2024. Different types of products such as surface, laser, topical, and injectable are majorly contributing to the scar treatment market size. The market has witnessed significant demand for topical over the last few years due to cost-effectiveness, easy application, easy availability, fewer side-effects, and to greater acceptance of creams and gels for healing scars, such as burns, acne, and surgical marks.
Explore more at: https://www.vynzresearch.com/healthcare/scar-treatment-market
Global Advanced Wound Care Market Analysis and Forecast to 2024
The global advanced wound care market is predicted to grow at 6.0% CAGR during the forecast period with the market size reaching USD 16.0 billion by 2024. Advanced wound care products are used for the treatment of chronic and acute wounds. These products manage the wound effectively and enable faster healing. Different products such as advanced, wound therapy device and active wound care products are majorly contributing to the advanced wound care market size.
Explore more at: https://www.vynzresearch.com/healthcare/advanced-wound-care-market
About VynZ Research
VynZ Research is a market research firm offering research, analytics, and consulting services on business strategies. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies. VynZ Research assists enterprises to take strategic decisions for helping their businesses to grow. The reports developed by VynZ are based on market facts that include comprehensive analysis and quantification of market drivers, industry dynamics, opportunities, challenges, threats, market shares and anticipated new trends & technologies arising across a wide range of industries.
Contact Us:
VynZ Research
Call: +91-996-028-8381
Toll-Free (U.S. and Canada): +1-888-253-3960
Email: enquiry@vynzresearch.com